ConforMIS Reports 1Q19 Revenue of $20.6MM, +5% vs. 1Q18

ConforMIS posts 1Q19 revenue of USD $20.6MM, +5% vs. 1Q18.

• U.S. revenue increased almost 10% driven by sales of iTotal PS
• iTotal PS sales grew 30% year over year
• iTotal PS now accounts for 37% of all product revenue, up from 30% last year
• Ex-U.S. sales continued to decline, especially in Germany
• Company faced operational issues with final stages of CAD outsourcing
• ConforMIS funded a study published in Clinical Orthopaedics and Related Research that examined the knee anatomy of 24,000 patients and showed a high degree of variability, supporting the use of customized knee implants

ConforMIS’ segment sales and growth on an as-reported basis are as follows ($MM).

* Limited launch 3Q18, full launch 2H19

ConforMIS’ product revenue by geographic region is as follows ($MM).

Net earnings are as follows.

Source: ConforMIS

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.